News

Filter

Current filters:

ChondroCelectOncology

126 to 135 of 96597 results

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

15-10-2014

There was good news for Japanese drugmaker Eisai yesterday, as the US Food and Drug Administration granted…

BanzelEisailenvatinibNeurologicalOncologyPharmaceuticalRegulationRufinamide TabletsUSA

Northwest Bio says DCVax-L hospital exemption program under way in Germany

Northwest Bio says DCVax-L hospital exemption program under way in Germany

15-10-2014

US biotech firm Northwest Biotherapeutics, which is developing DCVax personalized immune therapies for…

BiotechnologyDCVax-LGermanyNorthwest BiotherapeuticsOncologyRegulationResearch

Roche signs deal with DKSH to expand access across Asia

Roche signs deal with DKSH to expand access across Asia

15-10-2014

Switzerland-based market expansion services provider DKSH has signed an agreement with Swiss pharma major…

AsiaAsia-PacificDKSHManagementPharmaceuticalRocheRoche Thailand LimitedSwitzerland

Canadian drugmakers’ R&D spending drops to record low

Canadian drugmakers’ R&D spending drops to record low

15-10-2014

Spending by brand-name drug companies on R&D in Canada has dropped to the lowest level ever recorded,…

CanadaFinancialPharmaceuticalResearch

FDA consent decree with Ascend Labs backed by federal judge

FDA consent decree with Ascend Labs backed by federal judge

15-10-2014

A federal judge from the US District Court for the Southern District of Ohio entered a consent decree…

Ascend LaboratoriesGenericsLegalProductionRegulationUSA

Bruno Lucidi appointed permanent CEO of Karolinska Development

Bruno Lucidi appointed permanent CEO of Karolinska Development

15-10-2014

Swedish drug developer Karolinska Development has named Bruno Lucidi as permanent chief executive.

BoardroomKarolinska DevelopmentManagementPharmaceuticalSweden

NICE preliminary guidance negative on Celgene’s pomalidomide for multiple myeloma

NICE preliminary guidance negative on Celgene’s pomalidomide for multiple myeloma

15-10-2014

UK medical costs watchdog the National Institute for Health and Care Excellence (NICE) has issued preliminary…

BiotechnologyCelgene Corp.ImnovidOncologyPricingRegulationUK

AbbVie reconsidering $54.6 billion acquisition of Shire

AbbVie reconsidering $54.6 billion acquisition of Shire

15-10-2014

US drugmaker AbbVie has told Ireland-headquartered Shire of its board of directors' intention to meet…

AbbVieFinancialIrelandMergers & AcquisitionsPharmaceuticalShire

126 to 135 of 96597 results

Back to top